Dietary magnesium, not calcium, prevents vascular calcification in a mouse model for pseudoxanthoma elasticum
Open Access
- 23 February 2010
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 88 (5) , 467-475
- https://doi.org/10.1007/s00109-010-0596-3
Abstract
Pseudoxanthoma elasticum (PXE) is a heritable disorder characterized by ectopic calcification of connective tissue in skin, Bruch’s membrane of the eye, and walls of blood vessels. PXE is caused by mutations in the ABCC6 gene, but the exact etiology is still unknown. While observations on patients suggest that high calcium intake worsens the clinical symptoms, the patient organization PXE International has published the dietary advice to increase calcium intake in combination with increased magnesium intake. To obtain more data on this controversial issue, we examined the effect of dietary calcium and magnesium in the Abcc6 −/− mouse, a PXE mouse model which mimics the clinical features of PXE. Abcc6 −/− mice were placed on specific diets for 3, 7, and 12 months. Disease severity was measured by quantifying calcification of blood vessels in the kidney. Raising the calcium content in the diet from 0.5% to 2% did not change disease severity. In contrast, simultaneous increase of both calcium (from 0.5% to 2.0%) and magnesium (from 0.05% to 0.2%) slowed down the calcification significantly. Our present findings that increase in dietary magnesium reduces vascular calcification in a mouse model for PXE should stimulate further studies to establish a dietary intervention for PXE.Keywords
This publication has 32 references indexed in Scilit:
- Elevated Dietary Magnesium Prevents Connective Tissue Mineralization in a Mouse Model of Pseudoxanthoma Elasticum (Abcc6−/−)Journal of Investigative Dermatology, 2009
- Pseudoxanthoma elasticum: clinical phenotypes, molecular genetics and putative pathomechanismsExperimental Dermatology, 2008
- Ectopic mineralization of connective tissue in Abcc6–/– mice: effects of dietary modifications and a phosphate binder – a preliminary studyExperimental Dermatology, 2007
- Oral phosphate binders in the treatment of pseudoxanthoma elasticumJournal of the American Academy of Dermatology, 2005
- Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutationsJournal of Medical Genetics, 2005
- Does autosomal dominant pseudoxanthoma elasticum exist?American Journal of Medical Genetics Part A, 2003
- Analysis of the Frequent R1141X Mutation in theABCC6Gene in Pseudoxanthoma ElasticumInvestigative Opthalmology & Visual Science, 2003
- Extracutaneous Ultrastructural Alterations in Pseudoxanthoma ElasticumUltrastructural Pathology, 2003
- Mechanisms of Inhibition of CalcificationClinical Orthopaedics and Related Research, 1989
- High Mortality with Severe Dystrophic Cardiac Calcinosis in C3H/OUJ Mice Fed High Fat Purified DietsVeterinary Pathology, 1988